These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 10446073)

  • 1. Aortic plaque size and endometrial response in cholesterol-fed rabbits treated with estrogen plus continuous or sequential progestin.
    Brehme U; Bruck B; Gugel N; Wehrmann M; Hanke S; Finking G; Schmahl FW; Hanke H
    Arterioscler Thromb Vasc Biol; 1999 Aug; 19(8):1930-7. PubMed ID: 10446073
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of the protective effect of estrogen by progesterone in experimental atherosclerosis.
    Hanke H; Hanke S; Bruck B; Brehme U; Gugel N; Finking G; Mück AO; Schmahl FW; Hombach V; Haasis R
    Atherosclerosis; 1996 Mar; 121(1):129-38. PubMed ID: 8678917
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of hormone replacement therapy on endometrial histology in postmenopausal women. The Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial. The Writing Group for the PEPI Trial.
    JAMA; 1996 Feb; 275(5):370-5. PubMed ID: 8569016
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Different effects of estrogen and progesterone on experimental atherosclerosis in female versus male rabbits. Quantification of cellular proliferation by bromodeoxyuridine.
    Hanke H; Hanke S; Finking G; Muhic-Lohrer A; Mück AO; Schmahl FW; Haasis R; Hombach V
    Circulation; 1996 Jul; 94(2):175-81. PubMed ID: 8674176
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Progestins and menopause: epidemiological studies of risks of endometrial and breast cancer.
    Pike MC; Ross RK
    Steroids; 2000; 65(10-11):659-64. PubMed ID: 11108873
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estrogen-progestin replacement therapy and endometrial cancer.
    Pike MC; Peters RK; Cozen W; Probst-Hensch NM; Felix JC; Wan PC; Mack TM
    J Natl Cancer Inst; 1997 Aug; 89(15):1110-6. PubMed ID: 9262248
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparative study of the effects of an estradiol-releasing vaginal ring combined with an oral gestagen versus transdermal estrogen combined with a levonorgestrel-releasing IUD: clinical findings and endometrial response.
    Kalogirou D; Antoniou G; Karakitsos P; Kalogirou O; Antoniou D; Giannikos L
    Int J Fertil Menopausal Stud; 1996; 41(6):522-7. PubMed ID: 9010746
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of 17-beta estradiol on pre-existing atherosclerotic lesions: role of the endothelium.
    Hanke H; Kamenz J; Hanke S; Spiess J; Lenz C; Brehme U; Bruck B; Finking G; Hombach V
    Atherosclerosis; 1999 Nov; 147(1):123-32. PubMed ID: 10525133
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is estrogen plus progestin menopausal hormone therapy safe with respect to endometrial cancer risk?
    Trabert B; Wentzensen N; Yang HP; Sherman ME; Hollenbeck AR; Park Y; Brinton LA
    Int J Cancer; 2013 Jan; 132(2):417-26. PubMed ID: 22553145
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transdermal estrogen with a levonorgestrel-releasing intrauterine device for climacteric complaints: clinical and endometrial responses.
    Raudaskoski TH; Lahti EI; Kauppila AJ; Apaja-Sarkkinen MA; Laatikainen TJ
    Am J Obstet Gynecol; 1995 Jan; 172(1 Pt 1):114-9. PubMed ID: 7847516
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Links between hormone replacement therapy and neoplasia.
    Hulka BS
    Fertil Steril; 1994 Dec; 62(6 Suppl 2):168S-175S. PubMed ID: 7958013
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyproterone acetate could counteract the benefits of estradiol valerate in oophorectomized cholesterol-fed rabbits.
    Sanjuán A; Castelo-Branco C; Vicente JJ; Ascaso C; Ordi J; Casals E; Mercadé I; Escaramís G; Vanrell JA
    Menopause; 2002; 9(4):282-7. PubMed ID: 12082364
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk of endometrial cancer following estrogen replacement with and without progestins.
    Weiderpass E; Adami HO; Baron JA; Magnusson C; Bergström R; Lindgren A; Correia N; Persson I
    J Natl Cancer Inst; 1999 Jul; 91(13):1131-7. PubMed ID: 10393721
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 17beta-estradiol, gender independently, reduces atheroma development but not neointimal proliferation after balloon injury in the rabbit aorta.
    Finking G; Krauss N; Römer S; Eckert S; Lenz C; Kamenz J; Menke A; Brehme U; Hombach V; Hanke H
    Atherosclerosis; 2001 Jan; 154(1):39-49. PubMed ID: 11137081
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endometrial cancer and menopausal hormone therapy in the National Institutes of Health-AARP Diet and Health Study cohort.
    Lacey JV; Leitzmann MF; Chang SC; Mouw T; Hollenbeck AR; Schatzkin A; Brinton LA
    Cancer; 2007 Apr; 109(7):1303-11. PubMed ID: 17315161
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of the duration of progestin use on the occurrence of endometrial cancer in postmenopausal women.
    Archer DF
    Menopause; 2001; 8(4):245-51. PubMed ID: 11449081
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endometrial carcinoma risks among menopausal estrogen plus progestin and unopposed estrogen users in a cohort of postmenopausal women.
    Lacey JV; Brinton LA; Lubin JH; Sherman ME; Schatzkin A; Schairer C
    Cancer Epidemiol Biomarkers Prev; 2005 Jul; 14(7):1724-31. PubMed ID: 16030108
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Raloxifene inhibits cholesterol aortic content but not atherosclerotic plaque size in oophorectomised cholesterol-fed rabbits.
    Castelo-Branco C; Sanjuán A; Casals E; Ascaso C; Colodrón M; Vicente JJ; Mercader I; Escaramís G; Blümel JE; Ordi J; Vanrell JA
    J Obstet Gynaecol; 2004 Jan; 24(1):47-51. PubMed ID: 14675981
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patterns of postmenopausal progestin use with estrogen in relation to endometrial cancer (United States).
    Newcomb PA; Trentham-Dietz A
    Cancer Causes Control; 2003 Mar; 14(2):195-201. PubMed ID: 12749724
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Review of the endometrial effects of estrogens and progestins.
    Creasy GW; Kafrissen ME; Upmalis D
    Obstet Gynecol Surv; 1992 Sep; 47(9):654-78. PubMed ID: 1436909
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.